Patents by Inventor Warren G. Foster

Warren G. Foster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11965879
    Abstract: A method of detecting the expression level of miRNA markers in a biological sample obtained from a mammal is provided. The method incudes the steps of i) detecting the expression level of one or more miRNA markers selected from the group of miR-199a-3p, miR-143-3p, miR-340-5p, let-7b-5p, miR-21-5p, miR-17-5p, miR-20a-5p and miR-103a-3p, in the biological sample; ii) detecting the expression level of at least one miRNA reference marker selected from miR-148b-3p and miR-30e-5p in the biological sample; and iii) normalizing the expression level of the miRNA marker(s) against the expression level of the miRNA reference marker in the sample and in a control. The method is useful for the diagnosis of endometriosis, monitoring of patient response to treatment, and assessment of disease progression and/or severity.
    Type: Grant
    Filed: August 21, 2020
    Date of Patent: April 23, 2024
    Assignee: McMaster University
    Inventor: Warren G Foster
  • Publication number: 20210123910
    Abstract: A method of detecting the expression level of miRNA markers in a biological sample obtained from a mammal is provided. The method incudes the steps of i) detecting the expression level of one or more miRNA markers selected from the group of miR-199a-3p, miR-143-3p, miR-340-5p, let-7b-5p, miR-21-5p, miR-17-5p, miR-20a-5p and miR-103a-3p, in the biological sample; ii) detecting the expression level of at least one miRNA reference marker selected from miR-148b-3p and miR-30e-5p in the biological sample; and iii) normalizing the expression level of the miRNA marker(s) against the expression level of the miRNA reference marker in the sample and in a control. The method is useful for the diagnosis of endometriosis, monitoring of patient response to treatment, and assessment of disease progression and/or severity.
    Type: Application
    Filed: August 21, 2020
    Publication date: April 29, 2021
    Inventor: Warren G Foster
  • Publication number: 20020147155
    Abstract: Disclosed are methods of treating endometriosis in a woman or of preventing endometriosis in a woman at higher than normal risk of developing or suffering recurrence of endometriosis. The inventive methods involve administering to the woman a pharmaceutically acceptable composition containing an aryl hydrocarbon receptor binding ligand, such as indole-3-carbinol, indole-4-carbinol, indole-5-carbinol, diindolylmethane, tryptophan, tryptamine, indole acetic acid, or glucosinolate compounds.
    Type: Application
    Filed: April 6, 2001
    Publication date: October 10, 2002
    Inventors: Warren G. Foster, Sanjay Agarwal, Claude L. Hughes